Trials / Unknown
UnknownNCT02789475
DP-R212 Pharmacokinetic Study
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- Alvogen Korea · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
An open-label, multiple-dose study to evaluate the pharmacokinetic drug-drug interaction of amlodipine and rosuvastatin in healthy adult male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amlodipine | Amlodipine administration |
| DRUG | Rosuvastatin | Rosuvastatin administration |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-06-03
- Last updated
- 2016-06-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02789475. Inclusion in this directory is not an endorsement.